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Background. The United Kingdom human immunodeﬁciency virus (HIV) epidemic was historically dominated by HIV sub-
type B transmission among men who have sex with men (MSM). Now 50% of diagnoses and prevalent infections are among het-
erosexual individuals and mainly involve non-B subtypes. Between 2002 and 2010, the prevalence of non-B diagnoses among MSM
increased from 5.4% to 17%, and this study focused on the drivers of this change.
Methods. Growth between 2007 and 2009 in transmission clusters among 14 000 subtype A1, C, D, and G sequences from the
United Kingdom HIV Drug Resistance Database was analysed by risk group.
Results. Of 1148 clusters containing at least 2 sequences in 2007, >75% were pairs and >90% were heterosexual. Most clus-
ters (71.4%) did not grow during the study period. Growth was signiﬁcantly lower for small clusters and higher for clusters of
≥7 sequences, with the highest growth observed for clusters comprising sequences from MSM and people who inject drugs
(PWID). Risk group (P < .0001), cluster size (P < .0001), and subtype (P < .01) were predictive of growth in a generalized linear
model.
Discussion. Despite the increase in non-B subtypes associated with heterosexual transmission, MSM and PWID are at risk
for non-B infections. Crossover of subtype C from heterosexuals to MSM has led to the expansion of this subtype within the
United Kingdom.
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Of the multiple HIV subtypes and recombinant forms, subtype
C predominates globally [1] but in the United Kingdom from
the mid-1980s to around 1995, the epidemic was dominated
by subtype B among men who have sex with men (MSM) [2].
Subtype B remains individually the most prevalent subtype in
Europe (>80% of infections) [3] and in the United Kingdom
(approximately 40% of diagnoses) [4]. However, non-B sub-
types increased in prevalence in the United Kingdom, from
<25% of diagnoses in the early 1990s [5] to 60% in 2010 [4].
Rises have been seen in other European countries [6–8], al-
though in the United States only 3% of samples subtyped be-
tween 2004 and 2010 were non-B [9]. The increase in the
United Kingdom and other European countries corresponds
to growth in new HIV diagnoses among heterosexuals born
abroad: however, after 2005, new diagnoses among heterosexu-
als born outside the United Kingdom decreased from 4426 to
2688 in 2013 [10].
By 2010, heterosexually acquired infections represented
around half of United Kingdom diagnoses [10], of which 86%
were non-B [4]. Subtype is frequently used as a proxy for trans-
mission route in phylogenetic analyses of HIV [11, 12], although
the prevalence of non-B subtype infections among United
Kingdom–born MSM rose from 5.4% in 2007 [13] to 17% in
2010 [4].
Previous phylogenetic studies of subtype A and C sequences
revealed United Kingdom–speciﬁc clusters [11], including
among MSM [14], indicating some local transmission. Aggar-
wal et al investigated medical records and laboratory diagnostic
ﬁndings for a small cohort to determine whether patients had
been infected before or after arrival into the United Kingdom
[15], but such an intensive approach is infeasible at the national
level. Rice et al explored the origin of infections among hetero-
sexuals born abroad, based on a detailed analysis of CD4+ T-cell
count decline in combination with their date of entry in the
country [16]. These authors estimated that 73% of HIV-positive
heterosexuals born abroad with infection diagnosed in 2002
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were infected outside the United Kingdom but that, by 2011,
>50% were acquiring HIV within the United Kingdom [16].
This analysis was performed at the national level; however, it
did not discriminate the subepidemics associated with different
subtypes, and neither Aggarwal et al [15] nor Rice et al [16]
could distinguish infections acquired through travel following
domicile in the United Kingdom.
To analyze the recent transmission dynamics among non-B
HIV subtypes in the United Kingdom, we used an automated
phylogenetic clustering method [17]. We applied this approach
to data from the United Kingdom HIV Drug Resistance Data-
base (UKHIVRDB), which contains viral sequences from close
to 50% of individuals in the United Kingdom with diagnosed
HIV infection [4]. We quantiﬁed the transmission dynamics
of non-B subtypes across risk groups in the United Kingdom.
METHODS
For a description of the data set, see the Supplementary Table—
Data.
HIV Cluster Dynamics
Cluster Picking
We used the Cluster Picker and Cluster Matcher [17] to analyze
transmission dynamics. Phylogenetic trees were built in RaxML
[18] for each subtype separately against a background of global
sequences from the Los Alamos National Laboratory HIV data-
base (available at: http://www.hiv.lanl.gov). All A1, C, D, and G
pol sequences (HXB2 nucleotide positions 2253–3459) with a
minimum length of 500 base pairs, excluding those from the
United Kingdom, were downloaded from the Los Alamos Na-
tional Laboratory HIV database (>11 000 subtype C sequences
and >4000 sequences each of subtypes A, D, and G). To limit
the size of the trees, Viroblast [19] was used to select the 10
global background sequences closest to each UKHIVRDB se-
quence. In all 4 trees, clusters were picked if they contained at
least 2 sequences, bootstrap support was >90%, and maximum
pairwise genetic distance was ≤4.5%. A genetic distance thresh-
old of 4.5% has previously been determined to best delineate ep-
idemiologically relevant clusters in the United Kingdom [12].
We only analyzed clusters in which at least 80% of the sequenc-
es were from the United Kingdom, meaning that, for clusters of
≤4, all sequences had to be from the United Kingdom.
Cluster Dynamics
Clusters were sorted into risk groups based on self-identiﬁed
risk group information associated with each sequence in the
cluster. For clusters that contained at least 1 United Kingdom
sequence collected up to December 2007, we counted the num-
ber of United Kingdom sequences in the cluster collected prior
to December 2007 (hereafter, “old sequences”) and the number
of United Kingdom sequences added to the cluster after 2007
(hereafter, “new sequences”). We calculated cluster growth as
the number of new sequences divided by the number of old
sequences, expressed as a percentage increment based on initial
cluster size [20], and tested statistical signiﬁcance using the
Kruskal–Wallis test.
Simulations
We simulated phylogenies consistent with a simple epidemio-
logical model in which all individuals in the population are
equally likely to transmit, using custom R scripts according to
the method described by Alizon et al [21]. The distribution of
bootstrap support values and branch lengths were obtained
from the full trees (excluding global background sequences),
after which sequences collected after 2007 were stripped. New
infections were then simulated as branching events in the
tree. Given the incomplete coverage in the UKHIVRDB, the
probability of any branch being selected was proportional to
its length, to reﬂect the increased probability of missing HIV-
positive individuals (regardless of whether infection was diag-
nosed) occurring along long branches. The branch length and
bootstrap support for the new bifurcation were drawn at ran-
dom from the branch length and bootstrap distributions of
the full tree containing all sequences up to the end of 2009. Se-
quences were simulated along the resulting phylogenies under a
generalized time-reversible substitution model with nucleotide
frequencies from the original data by using SeqGen [22], ensur-
ing that the mean genetic distance among simulated sequences
was equivalent to that of the true sequences. This was repeated
1000 times for each tree. Clusters (≥90% bootstrap and ≤4.5%
genetic distance) were picked in the simulated trees, and cluster
growth was calculated as in the original trees, to generate ex-
pected cluster growth distributions for each subtype.
Generalized Linear Model (GLM)
We constructed a GLM expressing the number of new sequenc-
es as a variable dependent on the number of old sequences, risk
group, and subtype. We ﬁrst tested the distribution of the de-
pendent variable against Poisson, negative binomial, and
gamma distributions to verify that a GLMwould be appropriate.
The distribution of the number of new sequences was adequate-
ly ﬁtted by a negative binomial distribution (P = .1, by the χ2
test), with no other model offering a better ﬁt, and so we used
the negative binomial GLM available in R.
All statistical analyses were conducted in R [23].
RESULTS
We investigated the dynamics of transmission clusters of non-B
subtype HIV sequences between January 2007 and December
2009 to determine the drivers of new diagnoses during this pe-
riod. After exclusion of duplicates, the 2010 UKHIVRDB sub-
type A1 data set contained 2083 sequences, of which 630 were
collected after December 2006, and the subtype C data set con-
tained 10 830 sequences, including 4852 collected after 2006
(Supplementary Text—Data). Of 815 subtype D sequences,
279 were collected after 2006; and of 965 subtype G sequences,
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472 were collected after 2006. Thus, while the UKHIVRDB
subtype A1 and D data sets grew by approximately 50% during
the study period, the subtype C and G data sets grew by >80%.
To these were added >7000 non–United Kingdom sequences
selected by Viroblast (see “Methods” section) to distinguish
between United Kingdom and non–United Kingdom
transmission.
Cluster Composition
A total of 2327 clusters (304 A1, 1827 C, 112 D, and 125 G)
meeting the above criteria were identiﬁed in the four trees.
One hundred one clusters were excluded because <80% of the
sequences therein were from the United Kingdom, of which
only 26 contained >1 United Kingdom sequence. A total of
5999 United Kingdom sequences (41%) clustered with at least
one other United Kingdom sequence used in the phylogenetic
analysis. Over half of linked sequences were linked to only 1
other (hereafter, “pairs”; 3260 of 5999 sequences and 1630 of
2327 clusters). Clusters that contained >50% sequences with
no risk group (969 of 2327 [42%]) were not classiﬁed. From a
density plot to examine the risk group composition of each re-
maining cluster (Supplementary Figure 1), 4 groups clearly
emerged. The majority of clusters (1231 of 1358 [91%]) con-
tained sequences only from heterosexuals, and 31 clusters
(2.3%) comprised sequences only from MSM. Seventy-three
clusters (5.4%) contained sequences from both MSM and het-
erosexuals (at least 10% sequences from each). Finally, 24 clus-
ters (1.7%) comprised sequences from persons who inject drugs
(PWID; Figure 1). Some PWID clusters contained sequences
from MSM and/or heterosexuals, but all contained at least
25% sequences from PWID. The breakdown by cluster size
and risk group for clusters containing >1 risk group (all cross-
over clusters and PWID clusters that comprised >1 risk group)
is shown in Supplementary Figure 2. We conducted a sensitivity
analysis to test the effect of cluster classiﬁcation on our results
(Supplementary Figure 3).
Cluster Growth Depends on Initial Cluster Size
Of the 1148 clusters that existed (pairs or larger clusters) in Jan-
uary 2007, only a minority (328 of 1148 [28.6%]) grew during
the study period (Table 1). This effect was more pronounced in
subtypes A1, D, and G, where <20% of clusters changed, com-
pared with 33.5% in subtype C (P < .0001, by the Fisher exact
test; Table 1). Pairs were signiﬁcantly less likely to grow than
larger clusters (P < .0001). Among pairs, only 215 of 879
(24.5%) changed during the study period. Overall, of 6233
new non-B subtype sequences added to the database after Jan-
uary 2007, 1457 (23.4%) linked to sequences already in the da-
tabase before that date. This proportion was higher among
subtypes A1 (24.6%) and C (25.0%) than among subtypes D
(11.1%) and G (12.7%; P < .0001).
For clusters containing at least 1 sequence collected prior to
January 2007, we calculated growth as the number of sequences
collected after this date divided by the number of sequences al-
ready clustered. In the United Kingdom data, we observed a sig-
niﬁcantly different degree of growth between clusters of
different starting sizes (P < .0001, by the Kruskal–Wallis test;
4 degrees of freedom). We observed a trend of cluster growth
increasing with cluster size in 2007 for subtypes A1 and C
(Figure 2), which was signiﬁcant only for subtype C (r = 0.95
and P < .05). Single sequences collected prior to 2007 that
formed clusters after 2007 (total, 670 sequences) were not
included.
Figure 1. Risk group classification of clusters identified in 2009. A total of 2327
clusters (304 A1, 1785 C, 113 D, and 125 G) contained at least 2 sequences: 1630
clusters comprised pairs of sequences, and 697 comprised >2 sequences. Abbrevi-
ations: HET, heterosexual; MSM, men who have sex with men; PWID, people who
inject drugs; NA, not available.
Table 1. Proportion of Clusters Showing Growth Between 2007 and 2009
HIV Subtype,
Cluster Size
All Clusters,
Proportion (%)
Clusters Displaying Growth,
Proportion (%)
A1, C, D, G
Overalla 1148/1148 (100) 328/1148 (28.6)
2 sequences 879/1148 (76.6) 215/879 (24.5)
A1
Overalla 190/190 (100) 37/190 (19.5)
2 sequences 147/190 (77.4) 24/147 (16.3)
C
Overalla 792/792 (100) 265/792 (33.5)
2 sequences 614/792 (77.5) 175/614 (28.5)
D
Overalla 87/87 (100) 12/87 (13.8)
2 sequences 63/87 (72.4) 8/63 (12.7)
G
Overalla 79/79 (100) 14/79 (17.7)
2 sequences 55/79 (69.6) 8/55 (14.5)
Abbreviation: HIV, human immunodeficiency virus.
a Defined as those containing at least 1 sequence collected before December 2006.
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We adopted a simulation-based approach to test whether ob-
served cluster growth differed signiﬁcantly from that expected if
sequences were added to trees at random. If all individuals in a
population are equally likely to transmit, the probability of a
new infection linking to any speciﬁc infection from the original
population is equal to 1 over the total size of the population. Al-
though the entire population is not sampled, the full genetic di-
versity of the population is captured by the tree, and a new
infection unlinked to those previously sampled will fall on a
branch distant to the tree’s terminal nodes. The longer the
length of a single branch, the more likely it is that individuals
have been missed along that branch and that a newly identiﬁed
infection could occur along that branch. The probability of a
new infection being linked to any given cluster is proportional
to the size of that cluster.
Sequences collected after January 2007 were stripped from
the tree and added back, with the probability of attachment
based on the length of each branch and on the genetic distance
and bootstrap distributions from the original tree (see Meth-
ods). In each simulated tree, clusters were picked as described
previously, and the average cluster growth was calculated for
clusters of each starting size and each risk group.
In the simulated data, average expected growth values were
normally distributed (Figure 2). For clusters of each size, we
evaluated whether the observed value of cluster growth fell
within the 95% quantile estimates of the simulations (Table 2).
Figure 2. Cluster growth according to initial cluster size in 2007. For each cluster identified in 2009 containing at least 1 sequence collected before 2007, cluster growth was
calculated as the number of new sequences divided by the number of old sequences (pink or black triangles). In parallel, we conducted simulations to generate expected cluster
growth according to initial cluster size (blue or gray triangles). Data are from 1000 simulations, and mean values and distributions are shown. This figure is available in black and
white in print and in color online.
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For subtypes A1, D, and G, growth of pairs was below the 2.5%
quantile (P < .05) of growth in the simulations. In 2007, there
was a small number (8 of 792) of larger clusters (containing
≥7 sequences) in subtype C and none in the other subtypes.
For this group, growth was higher than the 97.5% quantile
(P < .05) of simulated clusters. All other values for cluster
growth fell within the 95% quantiles of the simulations.
Cluster Growth Is Higher For Non-Heterosexual Risk Groups
Analysis by risk group was performed on clusters containing at
least 2 sequences in 2007 (n = 1148). Growth differed signiﬁ-
cantly between risk groups when all subtypes were analyzed
together (P < .005, by the Kruskal–Wallis test; 4 degrees of free-
dom). Although MSM clusters (mean growth, 54%), PWID
clusters (mean growth, 64%), and crossover clusters (mean
growth, 44%) grew signiﬁcantly more than heterosexual clusters
(mean growth, 18%), this was also observed in the simulated
data (P < .0001; 4 degrees of freedom), owing to the differing
initial cluster size between risk groups (P < .0001; 4 degrees of
freedom). For subtypes A and C, cluster growth was higher in
the observed data than in the simulations for PWID, MSM, and
crossover clusters (Table 3 and Figure 3), indicating that cluster
size was not the driver.
Cluster Size and Risk Group Act Independently on Cluster Growth
To determine whether the effect of cluster size remained sig-
niﬁcant when risk group was accounted for, we constructed a
GLM expressing the number of new sequences as a variable
dependent on the number of old sequences, risk group, and
subtype. Risk group and number of old sequences were added
to the model sequentially, with risk group highly predictive
(P < .0001) and the addition of cluster size signiﬁcantly improv-
ing the ﬁt of the model (P < .0001, by the analysis of variance
likelihood ratio test). The difference in effect between subtypes
was highly signiﬁcant (P < .0001). There was no signiﬁcant
interaction between risk group and cluster size (P = .108). In
terms of effect, the model explained 24.75% of the variance in
growth: risk group accounted for 12.31%, initial cluster size for
9.32%, and subtype for 3.12%. Cluster growth was higher for
crossover clusters (P < .0001), PWID clusters (P < .05), and
MSM clusters (P < .01); higher for subtype C clusters (P < .01);
and increased with initial cluster size (P < .0001).
HIV Subtype C Is Increasingly Acquired in the United Kingdom, While
Subtypes D and G Are Imported
The ratio of clustering to nonclustering subtype C sequences in-
creased over time, indicating a rise in the proportion of local
subtype C transmissions, while this ratio decreased for subtypes
D and G (Supplementary Figure 4). For all clusters in 2009 con-
taining at least 1 sequence in 2007, we counted the number of
new sequences clustering in crossover and MSM clusters
(Table 4). When we looked at the proportion of new diagnoses
linking to crossover and MSM clusters (2%–3% of new diagnos-
es) as opposed to HET clusters, proportions were not different
across subtypes (P = .38, by the Fisher exact test), although
numbers were small for subtypes D and G, with only 90 new
diagnoses linking to subtype D and G clusters.
DISCUSSION
We have developed a novel phylogeny-based approach to gen-
erate null patterns of cluster growth with which to compare ob-
served growth. This method has the beneﬁt of not requiring all
the infections to be sampled, because the full genetic diversity of
the population is still captured by the phylogenetic tree. At least
25% of non-B subtype infections diagnosed between 2007 and
2009 were linked to previously diagnosed infections and are
likely to have been acquired within the United Kingdom.
Among preexisting clusters, we identiﬁed that cluster size and
Table 2. Mean Observed Cluster Growth and Expected Growth by Cluster
Size in 2007
HIV
Subtype
Initial
Cluster
Size
(2007)
Clusters,
No.
Observed
Growth
Expected
Growth
(2.5%
Quantile)
Expected
Growth
(97.5%
Quantile)
A1 2 147 0.094 0.097 0.196
C 7+ 8 0.990 0.000 0.857
D 2 63 0.071 0.075 0.256
G 2 55 0.100 0.145 0.439
Clusters are only shown if their observed growth did not fall within the 95% expected growth
quantiles (P < .05). Subtype C clusters with ≥7 sequences exceeded their expected growth,
while subtype A, D, and G clusters with 2 sequences grew less than expected. Observed
growth was calculated as the average growth for all clusters of the same initial cluster
size in 2007. Expected growth for clusters of each initial size was estimated on the basis
of 1000 simulations, and the 2.5% and 97.5% quantiles of each distribution are shown.
Abbreviation: HIV, human immunodeficiency virus.
Table 3. Mean Observed Cluster Growth and Expected Growth by Risk
Group
HIV
Subtype Risk Group
Clusters,
No.a
Observed
Growth
Expected
Growth
(2.5%
Quantile)
Expected
Growth
(97.5%
Quantile)
A1 MSMb 9 0.421 0 0.417
A1 PWIDb 2 0.833 0 0.750
C MSMb 10 0.640 0.050 0.550
C PWIDb 5 1.015 0 0.875
C Crossoverb 36 0.550 0.073 0.500
D NA 31 0.075 0.358 1
G Non-HET 6 0.056 0.130 0.462
Observed growth was calculated as the average growth for all clusters of the same risk
group. Expected growth for clusters of each risk group was estimated on the basis of
1000 simulations, and the 2.5% and 97.5% quantiles of each distribution are shown.
Abbreviations: HIV, human immunodeficiency virus; MSM, men who have sex with men;
NA, not available; non-HET, non-heterosexual; PWID, people who inject drugs.
a Defined as clusters containing at least 2 sequences collected before January 2007.
Clusters are only shown if their observed growth did not fall within the 95% expected
growth quantiles (P < .05).
b Groups with clusters that grew more than expected.
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risk group each independently predicted higher cluster growth.
We conclude that crossover to non-heterosexual risk groups has
resulted in increased United Kingdom–based transmission of
subtype C in particular, as has been observed in France [24].
However, the majority of clusters did not grow, and there
were important differences between the subtypes analyzed.
Subtypes C, A1, D, and G are the most common subtypes in
the United Kingdom, after subtype B, and are found predomi-
nantly among heterosexuals [11]. Subtype C infections are most
common in South Africa, subtype A and D infections are most
common in East Africa, and subtype G infection is most com-
mon inWest Africa [1]. Subtype A has entered the United King-
dom in parallel from Eastern Europe, where it is transmitted
among PWID [25], and this may account for the slightly higher
proportion of new subtype A sequences linking to PWID clus-
ters, compared with other subtypes (1.11% vs 0.78% for subtype
C). Around half of diagnoses in the United Kingdom every year
are now non-B subtypes, with subtype C alone accounting for
one third [4]. We found the overwhelming majority of clusters
to comprise sequences from heterosexuals, as expected. Howev-
er, clusters classiﬁed as comprising sequences from MSM or
PWID were signiﬁcantly more likely to link to new infections.
Crossover clusters containing sequences from both heterosexu-
als and MSM were also more likely to grow. For subtype C, the
number of newly clustering sequences in crossover clusters
greatly exceeded the expected number, based on the simulations
Figure 3. Cluster growth according to risk group. Observed cluster growth is shown as a pink or black triangle, and mean expected growth and distributions from 1000
simulations are shown in blue or gray. For subtypes D and G, because numbers of non-heterosexual (non-HET) clusters were small, these were amalgamated for analysis.
Abbreviations: MSM, men who have sex with men; NA, not available; PWID, people who inject drugs. This figure is available in black and white in print and in color online.
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and the clustering ratio increased, while the less abundant sub-
types D and G remained dominated by imports (Supplementary
Figure 4). Crossover of subtype B from MSM into heterosexuals
has previously been reported in the United Kingdom [26], with
Black-African men clustering exclusively with MSMmore likely
to self-identify as heterosexuals, compared with other ethnici-
ties. Such mixing could be responsible for the spread of non-
B subtypes among MSM. In contrast, the epidemic growth of
non-B subtypes among heterosexuals in the United Kingdom
appears limited, as previously suggested [16].
It is noteworthy that most preexisting clusters (>70%) did not
link to any new infections. Subtype A1, D, and G pairs grew less
than expected, with 85% not changing at all. The observation
that larger clusters act as a driving force for epidemic growth
is consistent with the hypothesis of preferential attachment
[27], whereby already highly connected individuals tend to
make proportionally more contacts over time. The United
Kingdom subtype B epidemic among MSM has previously
been suggested to be driven through a process of preferential at-
tachment [27], but because the MSM and heterosexual epidem-
ics have different epidemic structure [11, 12], we compared
cluster growth to a null model in which every person was equal-
ly likely to transmit. The GLM analysis showed that cluster size
remained signiﬁcant in the model even when risk group was
taken into account. One explanation for this phenomenon
could be that larger clusters comprise sequences from acutely
infected individuals who drive new infections [28, 29].
Although the relative frequencies of A1, C, D, and G in the
United Kingdom reﬂect their respective global prevalence [1],
we observed signiﬁcant differences in their patterns of growth.
Thus, the United Kingdom subtype G epidemic grew as much
as the subtype C epidemic (ie, >80% during the study period),
but most did not link to previous United Kingdom infections.
The ratio of clustering to nonclustering sequences for D and G
decreased between 2007 and 2009; we conclude that D and G
were not being transmitted as much as C within the United King-
dom. Meanwhile, several large clusters of subtype C sequences
from non-heterosexuals displayed cluster growth more similar
to that of subtype B [12], and numerous crossover events were
observed. We conclude that accelerated spread of non-B subtypes
has followed transmission into non-heterosexuals.
Our ﬁgure of 25% is, for several reasons, an underestimate of
the proportion of non-B strains acquired within the United
Kingdom. We will miss some infections acquired within the
United Kingdom because of late diagnosis and because of the
choice of clustering threshold, which may exclude some links
erroneously [30]. Heterosexuals are known to present later dur-
ing infection than MSM [10], and immigrant groups may be
particularly slow to engage with healthcare providers. Neverthe-
less, the representation of the UKHIVRDB is high, and over
time it will accumulate even late-presenting patients, so linkages
will increase. In addition, while there is an element of arbitrar-
iness in any selection of speciﬁc dates, choosing a cutoff of Jan-
uary 2007 equalized the number of sequences on either side in
Table 4. Number of Sequences Added to Clusters Between 2007 and 2009, According to Risk Group and to Cluster Size in 2007
HIV Subtype, Initial Cluster Size Crossover HET PWID MSM NA Total
A1
Overall 7/630 (1.11) 76/630 (12.1) 7/630 (1.11) 14/630 (2.22) 51/630 (8.1) 155/630 (24.6)
1 sequence 2 41 2 2 44 91
≥2 sequences 5 35 5 12 7 64
C
Overall 81/4852 (1.67) 620/4852 (12.78) 38/4852 (0.78) 40/4852 (0.82) 432/4852 (8.9) 1211/4852 (24.96)
1 sequence 15 362 5 7 320 709
≥2 sequences 66 258 33 33 112 502
D
Overall 2/279 (0.72) 14/279 (5.02) 1/279 (0.36) 1/279 (0.36) 13/279 (4.66) 31/279 (11.11)
1 sequence 0 8 1 1 7 17
≥2 sequences 2 6 0 0 6 14
G
Overall 9/472 (1.91) 30/472 (6.36) 3/472 (0.64) 0/472 (0) 18/472 (3.81) 60/472 (12.71)
1 sequence 9 14 2 0 15 40
≥2 sequences 0 16 1 0 3 20
All subtypes
Overall 99/6233 (1.59) 740/6233 (11.87) 49/6233 (0.79) 55/6233 (0.88) 514/6233 (8.25) 1457/6233 (23.38)
1 sequence 26 425 10 10 386 857
≥2 sequences 73 315 39 45 128 600
Data are no. of sequences added to all clusters of the risk group per cluster size of interest or no. of sequences added to all clusters of the risk group per cluster size of interest/total no. of new
sequences for each subtype (%).
Abbreviations: HET, heterosexual; HIV, human immunodeficiency virus; MSM, men who have sex with men; NA, not available; PWID, people who inject drugs.
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the 2010 release of the UKHIVRDB. As time-resolved trees of
the United Kingdom non-B epidemic previously showed that
sequences were added to clusters linearly with time [11] the
choice of cutoff is unlikely to inﬂuence results. The choice of
bootstrap and genetic distance cutoffs is subjective, but the
thresholds used here have been shown to appropriately delin-
eate epidemiologically relevant clusters in the United Kingdom
[12]. The same clusters are identiﬁed at a range of thresholds
[17], and so our ﬁndings are unlikely to be affected by our
choice of threshold. Finally, formal methods linking phyloge-
netic reconstructions and epidemiological models remain difﬁ-
cult to apply to large data sets. However, our use of simulations
as a null model to compare our data to has provided a direct test
and demonstrated that growth rates of clusters containing se-
quences from non-heterosexuals diverge dramatically from a
null model in which all individuals in the population are equally
likely to transmit. In previous analyses of cluster dynamics over
time, a formal comparison of observed cluster growth to the
growth expected given the change in the number of sequences
was not included [20, 28]. Brenner et al analyzed time-resolved
trees, which might be expected to improve estimation of the
timing of transmission events, but the method used here,
which is based on the dates of diagnosis, is applicable to
much larger data sets [28].
Overall, we found that the majority of clusters within the
United Kingdom non-B epidemic did not grow between 2007
and 2009 and those that did were more likely to already be larg-
er and to contain sequences from MSM or PWID. Subtype C
infections are increasingly being acquired within the United
Kingdom, while subtypes D and G infections remain domi-
nated by importation. We conclude that crossover into non-
heterosexual risk groups by 2010 led to rapid expansion of
non-B subtypes within the United Kingdom, a trend likely to
have continued. This study underlines the importance of con-
tinuing efforts to prevent HIV transmission among all risk
groups despite the United Kingdom epidemic changing from
predominately involving MSM and subtype B to being more di-
verse in terms of risk group and subtypes.
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